» Articles » PMID: 21938643

The Associations Among Coping, Nadir CD4+ T-cell Count, and Non-HIV-related Variables with Health-related Quality of Life Among an Ambulatory HIV-positive Patient Population

Overview
Journal Qual Life Res
Date 2011 Sep 23
PMID 21938643
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: We investigated HRQoL among HIV-positive outpatients from October, 2006-December, 2007, incorporating medical chart review, and a survey of coping styles.

Methods: Consented HIV-positive patients receiving medical care at University of Colorado Denver, with HAART as first antiretroviral regimen, completed the MOS-HIV and Brief COPE survey instruments. Linear regression identified a priori factors hypothesized to be associated with the MOS-HIV composite mental and physical health scores (MHS, PHS). Brief COPE survey maladaptive and adaptive coping components were added to the models and retained if significant.

Results: Among the 157 patient cohort, parsimonious multivariable linear regression models (P < 0.05) indicated higher nadir CD4+ T-cell counts and adaptive coping were associated with a higher MHS; public/no insurance, mental illness, current number of non-HIV medications, and maladaptive coping were inversely associated with MHS. Nadir CD4+ T-cell count and efavirenz use were associated with a higher PHS; mental illness, current number of non-HIV mediations, and maladaptive coping were inversely associated with PHS.

Conclusions: Factors independently associated with lower MHS and lower PHS include lower nadir CD4+ T-cell counts, and use of maladaptive coping. Efforts to reduce use of maladaptive coping strategies and earlier identification and treatment of HIV may improve HRQoL in HIV-positive patients.

Citing Articles

Health-Related Quality of Life in People with Advanced HIV Disease, from 1996 to 2021: Systematic Review and Meta-analysis.

Portilla-Tamarit I, Rubio-Aparicio M, Fuster-RuizdeApodaca M, Portilla-Tamarit J, Reus S, Portilla J AIDS Behav. 2024; 28(6):1978-1998.

PMID: 38743382 PMC: 11161547. DOI: 10.1007/s10461-024-04298-y.


Psychosocial predictors of quality of life among women living with HIV/AIDS: a cross-sectional study in a VCT centre in Shiraz, Iran.

Foroozanfar Z, Hooshyar D, Joulaei H Qual Life Res. 2024; 33(4):1063-1073.

PMID: 38231437 DOI: 10.1007/s11136-023-03586-9.


Health-related quality of life and associated factors among people living with HIV/AIDS in Sichuan, China: A cross-sectional study.

Zhong H, Wei F, Song Y, Chen H, Ni Z Front Public Health. 2023; 11:1133657.

PMID: 36992898 PMC: 10040810. DOI: 10.3389/fpubh.2023.1133657.


Post-Traumatic Stress Disorder and Coping Strategies Among People with HIV in Lira District, Uganda: A Cross-Sectional Study.

Arebo B, Ewach G, Omara J, Oyella P, Aciro Lucky R, Kabunga A HIV AIDS (Auckl). 2022; 14:255-264.

PMID: 35669392 PMC: 9166282. DOI: 10.2147/HIV.S358575.


Socio-demographic, clinical and service use determinants associated with HIV related stigma among people living with HIV/AIDS: a systematic review and meta-analysis.

Armoon B, Higgs P, Fleury M, Bayat A, Fattah Moghaddam L, Bayani A BMC Health Serv Res. 2021; 21(1):1004.

PMID: 34551772 PMC: 8459487. DOI: 10.1186/s12913-021-06980-6.


References
1.
Maggiolo F . Efavirenz: a decade of clinical experience in the treatment of HIV. J Antimicrob Chemother. 2009; 64(5):910-28. PMC: 2760464. DOI: 10.1093/jac/dkp334. View

2.
Jia H, Uphold C, Zheng Y, Wu S, Chen G, Findley K . A further investigation of health-related quality of life over time among men with HIV infection in the HAART era. Qual Life Res. 2007; 16(6):961-8. DOI: 10.1007/s11136-007-9214-4. View

3.
Palella Jr F, Delaney K, Moorman A, Loveless M, Fuhrer J, Satten G . Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998; 338(13):853-60. DOI: 10.1056/NEJM199803263381301. View

4.
Burgoyne R, Rourke S, Behrens D, Salit I . Long-term quality-of-life outcomes among adults living with HIV in the HAART era: the interplay of changes in clinical factors and symptom profile. AIDS Behav. 2004; 8(2):151-63. DOI: 10.1023/B:AIBE.0000030246.19577.fb. View

5.
Lichtenstein K, Armon C, Buchacz K, Chmiel J, Moorman A, Wood K . Initiation of antiretroviral therapy at CD4 cell counts >/=350 cells/mm3 does not increase incidence or risk of peripheral neuropathy, anemia, or renal insufficiency. J Acquir Immune Defic Syndr. 2007; 47(1):27-35. DOI: 10.1097/QAI.0b013e31815acacc. View